TLDR
- NuScale holds the distinction of being the sole U.S. nuclear firm with NRC approval for its SMR technology, providing a competitive regulatory advantage.
- First quarter 2026 revenue crashed to merely $565,000 — a 95.8% decline from the previous year — falling drastically short of the $7 million analyst forecast.
- Shares currently hover between $12 and $13, representing a steep 65% decline from year-ago levels, with the 52-week peak reaching $57.42.
- Major insider selling activity emerged, notably Director Corp Fluor dumping 13.5 million shares during April, netting over $159 million in proceeds.
- Analyst community consensus remains at “Hold” status with a mean price objective of $15.92, as institutional stakeholders control 78.37% of outstanding shares.
NuScale Power (SMR) shares are currently changing hands below the $13 threshold, marking a dramatic 65% decline from twelve months prior. This substantial disconnect between valuation and promise is capturing market attention — though the underlying fundamentals paint a nuanced picture.
NuScale Power Corporation, SMR
Thursday’s opening bell saw shares at $12.05, positioned within a 52-week trading corridor spanning $8.85 to $57.42. The company commands a market capitalization hovering between $4.4 and $4.5 billion — a substantial figure considering quarterly revenue totaled just $565,000.
The Q1 performance wasn’t merely disappointing — it dramatically undershot Wall Street’s $7 million revenue projection by a significant margin. Year-over-year revenue contracted 95.8%, while the firm registered a $57 million operating deficit for the three-month period.
NuScale disclosed Q1 earnings per share of -$0.14, falling short of the -$0.11 consensus forecast. Wall Street projects full-year EPS at -$0.79.
The Investment Thesis Supporting NuScale
The optimistic outlook centers on regulatory positioning. NuScale stands alone among U.S. nuclear reactor developers in securing NRC certification for its small modular reactor (SMR) architecture. Competitors including Oklo and Nano Nuclear Energy remain without this crucial approval and face potentially lengthy approval timelines.
NuScale maintains two pipeline projects under development. The company partners with a Romanian energy provider to construct a 462-megawatt facility at a decommissioned coal power location. Domestically, collaboration with partner ENTRA1 targets 6 gigawatts of SMR deployment capacity serving the Tennessee Valley Authority.
Both initiatives face completion horizons beyond 2030. Presently, NuScale operates as a pre-commercial enterprise carrying a multi-billion dollar market valuation.
The firm maintains substantial liquidity reserves — approximately $1 billion aggregate, encompassing $341 million in cash and cash equivalents. This financial cushion extends the operational runway, though it doesn’t produce immediate shareholder value.
Executive Share Disposals Amid Institutional Stability
Recent insider transaction patterns warrant scrutiny. Over the trailing 90-day window, company insiders liquidated more than 40 million shares valued at approximately $475 million. The most significant transaction involved Director Corp Fluor disposing of 13.5 million shares throughout April at a $11.81 average execution price, generating proceeds exceeding $159 million.
Company insiders currently maintain ownership of merely 1.28% of outstanding equity.
Conversely, institutional investment firms retain 78.37% ownership stakes. Seven Grand Managers LLC established a fresh position valued at $1.77 million during Q4. Multiple additional funds — encompassing MAI Capital Management and Harbour Investments — expanded existing holdings.
Wall Street sentiment remains divided. B. Riley reduced its price objective from $24 to $19 while maintaining a “Buy” recommendation. HSBC initiated coverage assigning a “Hold” rating with a $13 target. Royal Bank of Canada lowered its target from $21 down to $14. TD Cowen downgraded the stock from “Buy” to “Hold” this past February.
Across 17 covering analysts, the prevailing consensus stands at “Hold,” featuring an average price target of $15.92 — roughly 25% premium to current trading levels.
NuScale’s 50-day simple moving average registers at $11.41 while the 200-day moving average sits at $15.38, with shares presently trading in the middle of these technical benchmarks.
